Hisamitsu Pharmaceutical Co. (HTSUF) reported earnings for full year that Dropped, from last year
The company's bottom line came in at JPY19.160 billion, or JPY268.22 per share. This compares with JPY21.758 billion, or JPY295.15 per share, last year.
The company's revenue for the period rose 4.5% to JPY163.024 billion from JPY156.006 billion last year.
Hisamitsu Pharmaceutical Co. earnings at a glance (GAAP) :
-Earnings: JPY19.160 Bln. vs. JPY21.758 Bln. last year.-EPS: JPY268.22 vs. JPY295.15 last year.-Revenue: JPY163.024 Bln vs. JPY156.006 Bln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.